News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,477 Results
Type
Article (41057)
Company Profile (258)
Press Release (668162)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (206898)
Career Advice (2021)
Deals (35846)
Drug Delivery (96)
Drug Development (81382)
Employer Resources (172)
FDA (16407)
Job Trends (15000)
News (349097)
Policy (32880)
Tag
Academia (2599)
Accelerated approval (5)
Adcomms (20)
Allergies (87)
Alliances (50401)
ALS (93)
Alzheimer's disease (1405)
Antibody-drug conjugate (ADC) (134)
Approvals (16403)
Artificial intelligence (275)
Autoimmune disease (23)
Automation (16)
Bankruptcy (364)
Best Places to Work (11712)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (178)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (294)
Cancer (2326)
Cardiovascular disease (180)
Career advice (1690)
Career pathing (30)
CAR-T (155)
Cell therapy (435)
Cervical cancer (21)
Clinical research (66294)
Collaboration (858)
Company closure (2)
Compensation (558)
Complete response letters (19)
COVID-19 (2618)
CRISPR (42)
C-suite (254)
Cystic fibrosis (102)
Data (2307)
Decentralized trials (2)
Denatured (19)
Depression (46)
Diabetes (276)
Diagnostics (6770)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (103)
Drug shortages (25)
Duchenne muscular dystrophy (97)
Earnings (87825)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (114068)
Executive appointments (745)
FDA (17784)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (774)
Gene editing (111)
Generative AI (24)
Gene therapy (311)
GLP-1 (717)
Government (4473)
Grass and pollen (4)
Guidances (150)
Healthcare (19035)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (122)
Indications (29)
Infectious disease (2764)
Inflammatory bowel disease (144)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (98)
Interviews (315)
IPO (16687)
IRA (41)
Job creations (3696)
Job search strategy (1435)
Kidney cancer (10)
Labor market (43)
Layoffs (478)
Leadership (17)
Legal (7964)
Liver cancer (78)
Lung cancer (327)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (325)
MASH (73)
Medical device (13565)
Medtech (13570)
Mergers & acquisitions (19726)
Metabolic disorders (704)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (92)
Neuropsychiatric disorders (27)
Neuroscience (1957)
NextGen: Class of 2025 (6566)
Non-profit (4545)
Now hiring (40)
Obesity (372)
Opinion (206)
Ovarian cancer (80)
Pain (92)
Pancreatic cancer (88)
Parkinson's disease (151)
Partnered (21)
Patents (241)
Patient recruitment (116)
Peanut (47)
People (58066)
Pharmaceutical (64)
Pharmacy benefit managers (19)
Phase I (20648)
Phase II (29213)
Phase III (21739)
Pipeline (1347)
Policy (147)
Postmarket research (2568)
Preclinical (8796)
Press Release (66)
Prostate cancer (108)
Psychedelics (32)
Radiopharmaceuticals (255)
Rare diseases (384)
Real estate (6003)
Recruiting (65)
Regulatory (22580)
Reports (47)
Research institute (2367)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (72)
Series A (132)
Series B (89)
Service/supplier (12)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (30)
Startups (3672)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (48)
The Weekly (31)
Vaccines (699)
Venture capitalists (43)
Weight loss (236)
Women's health (36)
Worklife (16)
Date
Last 7 days (931)
Last 30 days (2990)
Last 365 days (32646)
2025 (11785)
2024 (35584)
2023 (40489)
2022 (51613)
2021 (56173)
2020 (54638)
2019 (47032)
2018 (35458)
2017 (32553)
2016 (32032)
2015 (38167)
2014 (31833)
2013 (26937)
2012 (29124)
2011 (29820)
2010 (27799)
Location
Africa (734)
Alabama (54)
Alaska (7)
Arizona (235)
Arkansas (13)
Asia (38700)
Australia (6345)
California (6425)
Canada (2067)
China (536)
Colorado (272)
Connecticut (281)
Delaware (156)
Europe (83893)
Florida (947)
Georgia (218)
Idaho (57)
Illinois (552)
India (25)
Indiana (320)
Iowa (11)
Japan (172)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (923)
Massachusetts (4755)
Michigan (223)
Minnesota (409)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (66)
New Jersey (1790)
New Mexico (30)
New York (1813)
North Carolina (1026)
North Dakota (8)
Northern California (2813)
Ohio (210)
Oklahoma (14)
Oregon (35)
Pennsylvania (1417)
Puerto Rico (13)
Rhode Island (33)
South America (1115)
South Carolina (25)
South Dakota (1)
Southern California (2429)
Tennessee (105)
Texas (953)
United States (24080)
Utah (191)
Virginia (151)
Washington D.C. (64)
Washington State (574)
West Virginia (3)
Wisconsin (66)
709,477 Results for "paradigm diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)
May 7, 2025
·
5 min read
Press Releases
Cybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003
April 23, 2025
·
7 min read
Press Releases
Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results
May 9, 2025
·
9 min read
Press Releases
Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients
March 10, 2025
·
9 min read
Press Releases
Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split
May 8, 2025
·
4 min read
Press Releases
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
April 29, 2025
·
1 min read
Press Releases
Icotrokinra Clinical Study Results Demonstrate Its Potential to Shift Treatment Paradigm and Set a New Standard for Treatment in Plaque Psoriasis
March 10, 2025
·
16 min read
Press Releases
Axsome Therapeutics Announces Topline Results of PARADIGM Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (MDD) with and without Excessive Daytime Sleepiness (EDS)
April 1, 2025
·
7 min read
Press Releases
Hengrui’s Camrelizumab Combo Therapy Doubles the Five -Year Survival of Patients with Advanced Squamous Lung Cancer - A Potential Paradigm Shift in Clinical Outcome for this Difficult-to Treat Population
April 1, 2025
·
2 min read
Press Releases
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results
March 28, 2025
·
10 min read
1 of 70,948
Next
